PTC923 (CNSA-001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PTC923 (CNSA-001), covering 2023-11-14 to 2023-11-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia [Phase 1, Phase 2]